RNA-binding Motif Protein 39 (RBM39), a splicing factor implicated in cancer progression, interacts with transcriptional regulators such as AP-1 and NF-κB, suggesting a potential role in HIV-1 latency [9–13]. This evidence concerns the gene RBM39 and cancer.